🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Marleen Kok

The Netherlands Cancer Institute

ORCID: 0000-0001-9043-9815

Also affiliated with Oncode Institute

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.558Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Automated classification of cellular expression in multiplexed imaging data with Nimbus

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.06.02.597062
Top 35%
0.558DataRank
Top 35%9 citations

Noah F. Greenwald, Jolene S. Ranek, Potchara Boonrat, Cameron Walker, Jannik Franzen +15 more

Papers

Driven by 10 papers — median percentile 65. Top paper: “The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group”.

The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

npj Breast Cancer(2021)10.1038/s41523-021-00346-1
N/A
4.9DataRank · unranked
281 citations

Harry R. Haynes, Elizabeth F. Blackley, Susan Fineberg, Jeffrey Shear, Sophia Turner +73 more

Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group

npj Breast Cancer(2020)10.1038/s41523-020-0154-2
N/A
3.5DataRank · unranked
168 citations

Elisabeth Specht Stovgaard, Eva Balslev, Jeppe Thagaard, Weijie Chen, Sarah Dudgeon +95 more

Automated classification of cellular expression in multiplexed imaging data with Nimbus

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.06.02.597062
Top 35%
0.558DataRank
Top 35%9 citations

Noah F. Greenwald, Jolene S. Ranek, Potchara Boonrat, Cameron Walker, Jannik Franzen +15 more

Automated classification of cellular expression in multiplexed imaging data with Nimbus

Nature Methods(2025)10.1038/s41592-025-02826-9
N/A
0.312DataRank · unranked
7 citations

Noah F. Greenwald, Jolene S. Ranek, Potchara Boonrat, Cameron Walker, Jannik Franzen +16 more

Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer

Nature Communications(2022)10.1038/s41467-022-31238-y
N/A
0DataRank · unranked
76 citations

Filomena Housley, Christina Yau, Rachel Nakagawa, Juliane Winkler, Johanna M. Anttila +18 more

Validation of cancer-type-dependent benefit from immune checkpoint blockade in TMB-H tumors identified by the FoundationOne CDx assay

Annals of Oncology(2022)10.1016/j.annonc.2022.07.009
N/A
0DataRank · unranked
8 citations

P.G. Pilié, N.U. Rashid, Leonie Voorwerk, Maarten Slagter, Marleen Kok +8 more

Reply to: ‘Real-world prevalence across 159 872 patients with cancer supports the clinical utility of TMB-H to define metastatic solid tumors for treatment with pembrolizumab.’ by D. Fabrizio et al.

Annals of Oncology(2021)10.1016/j.annonc.2021.06.017
N/A
0DataRank · unranked
2 citations

P.G. Pilié, N.U. Rashid, Leonie Voorwerk, Maarten Slagter, Marleen Kok +8 more

The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers

Molecular Cancer Research(2020)10.1158/1541-7786.mcr-19-1082
N/A
0DataRank · unranked
64 citations

Stacey E. P. Joosten, Svetlana E. Semina, Luis H. Alejo, Svitlana D. Brovkovych, Joshua D. Stender +8 more

High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types

Annals of Oncology(2021)10.1016/j.annonc.2021.02.006
N/A
0DataRank · unranked
1067 citations

P.G. Pilié, N.U. Rashid, Leonie Voorwerk, Maarten Slagter, Marleen Kok +11 more

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

npj Breast Cancer(2020)10.1038/s41523-020-0156-0
N/A
0DataRank · unranked
208 citations

Elvire Roblin, Rim S. Kim, Stefan Michiels, Brandon D. Gallas, Weijie Chen +95 more